From Pfizer to AstraZeneca and the Omnicom-IPG Merger, the industry has seen a number of executive moves during this year.

Anthony Olson was told that he’d die without the treatment and to ignore a negative biopsy. He’s one of many patients who may have received harmful or unnecessary treatments from Montana oncologist Dr ...

It seems simple: Require hospitals and insurers to post their negotiated prices for most health care services and — bingo — competition follows, yielding lower costs for consumers. But nearly four ...

The healthcare technology solutions firm is saying goodbye to CEO William J. Febbo, who is leaving the company effective ...

Corcept’s first hypercortisolism awareness and screening campaign highlights the prevalence of what was long thought to be a very rare condition.

The Biden administration hasn’t delivered on its goals of measuring the public health impact of abortion bans. Experts say it ...

The first procedure was listed as “colonoscopy and biopsy,” while the second was listed as “colonoscopy w/lesion removal.” ...

Big moments filled pharma marketing’s 2024. Pfizer made the leap into the Super Bowl, a number of campaigns won big in Cannes ...

Nearly 70 government officials, farmers and farmworkers, and researchers with expertise in virology, pandemics and more weigh ...

Grady brings over 30 years of creative advertising experience, and is looking to shake up the industry with authentic ...

The Advanced Research Projects Agency for Health (ARPA-H) awarded TigaTx up to $33.5 million in funding. Tessera Therapeutics ...

On Wednesday, current OHG CEO Matt McNally removed his name from the equation by revealing he’s leaving the organization.